Amplitude Surgical SAS - Asset Resilience Ratio
Amplitude Surgical SAS (AMPLI) has an Asset Resilience Ratio of 0.71% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Amplitude Surgical SAS (AMPLI) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Amplitude Surgical SAS's Asset Resilience Ratio has changed over time. See AMPLI book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Amplitude Surgical SAS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AMPLI stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €2.00 Million | 0.71% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €2.00 Million | 0.71% |
Asset Resilience Insights
- Limited Liquidity: Amplitude Surgical SAS maintains only 0.71% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Amplitude Surgical SAS Industry Peers by Asset Resilience Ratio
Compare Amplitude Surgical SAS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Amplitude Surgical SAS (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Amplitude Surgical SAS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.88% | €2.45 Million ≈ $2.86 Million |
€279.25 Million ≈ $326.48 Million |
+0.80pp |
| 2023-06-30 | 0.07% | €196.00K ≈ $229.14K |
€266.02 Million ≈ $311.00 Million |
+0.00pp |
| 2022-06-30 | 0.07% | €186.00K ≈ $217.45K |
€259.46 Million ≈ $303.34 Million |
+0.03pp |
| 2021-06-30 | 0.04% | €111.00K ≈ $129.77K |
€269.07 Million ≈ $314.57 Million |
+63.01pp |
| 2020-06-30 | -62.97% | €-173.31 Million ≈ $-202.61 Million |
€275.20 Million ≈ $321.74 Million |
-63.00pp |
| 2019-06-30 | 0.03% | €70.00K ≈ $81.84K |
€279.92 Million ≈ $327.26 Million |
-4.60pp |
| 2018-06-30 | 4.62% | €13.33 Million ≈ $15.58 Million |
€288.20 Million ≈ $336.94 Million |
-0.24pp |
| 2017-06-30 | 4.86% | €13.17 Million ≈ $15.40 Million |
€270.96 Million ≈ $316.78 Million |
-- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more